Publication Name	World Journal of Gastroenterology
Manuscript ID	61479
Country	China

Received	2020-12-08 13:57
Peer-Review Started	2020-12-08 13:58
To Make the First Decision
Return for Revision	2020-12-31 01:20
Revised	2021-01-11 10:24
Second Decision	2021-01-30 14:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-02-01 22:36
Articles in Press	2021-02-01 22:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-02-11 01:46
Typeset the Manuscript	2021-03-01 01:17
Publish the Manuscript Online	2021-03-03 10:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Minireviews
Article Title	Interaction between hepatitis B virus and SARS-CoV-2 infections
Manuscript Source	Invited Manuscript
All Author List	Tian-Dan Xiang and Xin Zheng
Funding Agency and Grant Number
Corresponding Author	Xin Zheng, MD, PhD, Professor, Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China. xin11@hotmail.com
Key Words	COVID-19; Hepatitis B virus; Liver injury; SARS-CoV-2; Co-infection; Immune exhaustion
Core Tip	Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a global public health crisis. Liver impairment is frequent in COVID-19 regardless of whether it is combined with hepatitis B virus (HBV) infection. Currently, there is no evidence to suggest that HBV increases susceptibility to SARS-CoV-2. HBV and SARS-CoV-2 co-infection does not increase the risk of severity and outcome of COVID-19. Nucleoside analogs are recommended due to the risk of HBV reactivation in COVID-19.
Publish Date	2021-03-03 10:02
Citation	Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793
URL	https://www.wjgnet.com/1007-9327/full/v27/i9/782.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i9.782

Full Article (PDF)	WJG-27-782.pdf
Full Article (Word)	WJG-27-782.docx
Manuscript File	61479-Review-Filipodia-CL.docx
Answering Reviewers	61479-Answering reviewers.pdf
Audio Core Tip	61479-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	61479-Conflict-of-interest statement.pdf
Copyright License Agreement	61479-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	61479-Language certificate.pdf
Peer-review Report	61479-Peer-review(s).pdf
Scientific Misconduct Check	61479-Scientific misconduct check.pdf
Scientific Editor Work List	61479-Scientific editor work list.pdf